Hematopoietic Stem Cell Transplantation

As the center with the highest number of transplant cases and the most experience in central and southern Taiwan, we successfully receive referrals from both domestic and international patients. We actively develop various transplant methods, such as haploidentical transplantation to enhance transplant opportunities; CD45RA cell-depleted transplantation to reduce rejection risks, making us the only hospital in Taiwan with such experience; and total marrow and lymph node irradiation to minimize side effects from traditional radiation therapy, currently with the highest number of cases in Taiwan. We also utilize CIK therapy for minimal residual disease in blood cancers.

Clinical Trials

We actively introduce various new drug clinical trials and Phase I clinical trials, aligning with the most advanced international treatments. Collaborating with internationally renowned pharmaceutical companies, we promote clinical trials for new drugs and medical technologies, providing cancer patients with new treatment opportunities and establishing an important clinical trial hub in Taiwan.

CAR-T

We have accumulated clinical experience in CAR-T therapy for hematology malignancy, led by experienced specialists to ensure the safety of the CAR-T cell treatment process. We also actively engage in domestic and international clinical research to continuously improve treatment protocols. CAR001 utilizes genetically modified γδ T cells to precisely target tumor cells, promising new breakthroughs in cancer treatment in the future.